Results 201 to 210 of about 2,327,860 (219)

Thrombolysis With Recombinant Tissue-Type Plasminogen Activator in Renal Venous Thrombosis in Infancy

Lancet, The, 1992
W Kreuz, U Nowak-Göttl, R Schlösser
exaly  

Eligibility for Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke

Stroke, 2004
Pancioli Arthur, Edward Jauch, Brett M. Kissela   +2 more
exaly  

Randomised Controlled Trial of Recombinant Tissue Plasminogen Activator Versus Urokinase in the Treatment of Acute Pulmonary Embolism.

Lancet, The, 1988
D E Vaughan, J Anthony Parker
exaly  

Local Recombinant Tissue Plasminogen Activator to Clear Cerebral Artery Thrombosis Developing Soon After Surgery.

Lancet, The, 1988
P Courtheoux
exaly  

Gender Differences in Exclusion Criteria for Recombinant Tissue-Type Plasminogen Activator

Journal of Stroke and Cerebrovascular Diseases, 2016
Thomas I Nathaniel
exaly  

246 Effectors of the activation of human [GLU1] plasminogen by recombinant tissue plasminogen activator

Fibrinolysis, 1988
V.S. de Serrano, T. Urano, P.J. Gaffney, F.J. Castellino   +3 more
openaire   +1 more source

Explicit Consideration of Baseline Factors to Assess Recombinant Tissue-Type Plasminogen Activator Response With Respect to Race and Sex

Stroke, 2013
Amelia K Boehme, Andrei V. Alexandrov, Sharyl R Martini   +2 more
exaly  

Treatment of Prosthetic Tricuspid Valve Thrombosis With Recombinant Tissue-Type Plasminogen Activator

European Heart Journal, 1987
Hilaire de Geest, F van de Werf, D Collen   +2 more
exaly  

Aspirin/unspecified recombinant tissue plasminogen activator

Reactions Weekly, 2018
openaire   +1 more source

Successful Treatment of Neonatal Arterial Thromboses With Recombinant Tissue Plasminogen Activator

Journal of Pediatrics, 1998
Gary M Weiner, Roger G Faix
exaly